Antengene News and Activities

Antengene is a company listed under the stock ticker 6996 (CN).

View the org chart displaying its 14 main executives

Most searched biographies at Antengene

• Jay Mei, Chairman of the Board and Chief Executive Officer
• Sheng Tang, Independent Non-Executive Director
• Rafael Fonseca, Director

Popular executive movements at Antengene

• Bing Hou, who was Vice President, Head of Disovery Science and Translational Medicine, is promoted to Chief Scientific Officer  (posted on May 20 2026).

Create your alert
to follow the executive moves at Antengene.

Antengene has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Antengene

• Newsroom
• Newsroom
• Antengene announces preclinical study results on PD-L1/4-1BB bispecific antibody ATG-101
• China's NMPA approves Antengene’s XPOVIO for DLBCL treatment
• Antengene Advances ATG-022 in Phase II CLINCH Study for Solid Tumors in China and Australia,
• Antengene Announces XPOVIO® National Health Insurance Service Approval for Reimbursement in South Korea
• Newsroom
• Newsroom
• Newsroom
• Newsroom
• View more press releases Close

Social media about Antengene

• Antengene on Wikipedia, Google News & Yahoo Finance
• Antengene on LinkedIn, X (Twitter) & YouTube